TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11246064

Group type: EXPERIMENTAL
Intervention: Usual post-discharge care in Australia (n=100)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual post-discharge care in Scotland (n=75)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Usual post-discharge care in Australia
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual post-discharge care in Scotland
Number of subjects: 200
Study: 9842819

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 0.5% ropivacaine
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine
Number of subjects: 75
Study: 8084623

Group type: EXPERIMENTAL
Intervention: Stapedotomy with stapedius tendon preservation
Number of subjects: 1323

Group type: COMPARATOR
Intervention: Stapedectomy and stapedotomy with tendon section
Number of subjects: 1323
Study: 2721108

Group type: COMPARATOR
Intervention: Cefotaxime alone in healthy volunteers
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Cefotaxime in ESRD
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Cefotaxime with mezlocillin in healthy volunteers
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Cefotaxime with mezlocillin in ESRD
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Desacetyl cefotaxime in ESRD
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Mezlocillin in ESRD
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Cefotaxime with mezlocillin
Number of subjects: 13
Study: 31022313

Group type: EXPERIMENTAL
Intervention: Group cognitive‐behavioral therapy with exposure (CBT ERP)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Active control
Number of subjects: 31
Study: 27810663

Group type: EXPERIMENTAL
Intervention: M4 group (multiple-modality exercise + mind-motor training)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: M4 group
Number of subjects: 127

Group type: COMPARATOR
Intervention: M2 group (multiple-modality exercise + balance training)
Number of subjects: 127

Group type: COMPARATOR
Intervention: M2 group
Number of subjects: 127
Study: 26142612

Group type: EXPERIMENTAL
Intervention: Antidepressant continuation (AD)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Antidepressant discontinuation (C)
Number of subjects: 68
Study: 22648923

Group type: EXPERIMENTAL
Intervention: Omentoplasty
Number of subjects: 184

Group type: COMPARATOR
Intervention: Non-omentoplasty
Number of subjects: 184
Study: 21291529

Group type: EXPERIMENTAL
Intervention: Epirubicin
Number of subjects: 211

Group type: COMPARATOR
Intervention: Epirubicin and Tamoxifen
Number of subjects: 211
Study: 18804207

Group type: EXPERIMENTAL
Intervention: Preimplantation genetic screening (PGS)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Routine IVF (Control)
Number of subjects: 47
Study: 16208050

Group type: COMPARATOR
Intervention: Modified Mini-Mental State Examination (MMSE) administered to Group A (non-neurological illness)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Modified Mini-Mental State Examination (MMSE) administered to Group B (encephalopathy)
Number of subjects: 100
Study: 10599952

Group type: EXPERIMENTAL
Intervention: Lidocaine (600 mg + 5 microg/ml adrenaline)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Articaine (600 mg + 5 microg/ml adrenaline)
Number of subjects: 30
Study: 7867179

Group type: EXPERIMENTAL
Intervention: Gianturco‐Roubin stent (n = 33)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control (medical therapy only, n = 33)
Number of subjects: 66
Study: 1784628

Group type: EXPERIMENTAL
Intervention: 25 mg miglitol
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: 50 mg miglitol
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: 100 mg miglitol
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 6177276

Group type: EXPERIMENTAL
Intervention: Preoperative normovolemic hemodilution with dextran 70
Number of subjects: 2

Group type: COMPARATOR
Intervention: Conventional bank blood transfusion
Number of subjects: 2
Study: 29450728

Group type: EXPERIMENTAL
Intervention: 20 µg/day of vitamin D3
Number of subjects: 117

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study: 29961638

Group type: EXPERIMENTAL
Intervention: 3D intervention (patient-centred care model)
Number of subjects: 1546

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1546
Study: 26789872

Group type: EXPERIMENTAL
Intervention: Eluxadoline 75 mg
Number of subjects: 2427

Group type: EXPERIMENTAL
Intervention: Eluxadoline 100 mg
Number of subjects: 2427

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2427

Group type: EXPERIMENTAL
Intervention: Eluxadoline (75 mg and 100 mg combined)
Number of subjects: 2427
Study: 24440365

Group type: EXPERIMENTAL
Intervention: Assistance training
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 30
Study: 22052170

Group type: EXPERIMENTAL
Intervention: Intensive timing induction chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard timing induction chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chemotherapy intensification
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Allogeneic stem cell transplantation (SCT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Autologous SCT
Number of subjects: 0
Study: 21055713

Group type: EXPERIMENTAL
Intervention: Improved renal function
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Worsening renal function
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Any significant change in renal function (positive or negative)
Number of subjects: 401

Group type: COMPARATOR
Intervention: Stable renal function
Number of subjects: 401
Study: 17010554

Group type: EXPERIMENTAL
Intervention: Arthritis Self-Management Programme (ASMP) with added exercise component for 6 weeks
Number of subjects: 182

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 182
Study: 15769772

Group type: EXPERIMENTAL
Intervention: Community-based care (CBC)
Number of subjects: 364

Group type: COMPARATOR
Intervention: Enhanced primary care (EPC)
Number of subjects: 364
Study: 11991913

Group type: EXPERIMENTAL
Intervention: Nurse specialists in Parkinson's disease
Number of subjects: 1859
Study: 9808823

Group type: EXPERIMENTAL
Intervention: Outcall only
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Advance invitation + outcall
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 7700742

Group type: EXPERIMENTAL
Intervention: Sn-mesoporphyrin (SnMP) 6 mumol/kg birth weight
Number of subjects: 66

Group type: COMPARATOR
Intervention: Phototherapy (PT) using Phillips F20T12/BB lamps
Number of subjects: 66
Study: 2694745

Group type: EXPERIMENTAL
Intervention: 4 mm Dilapan tent for 3-4 hours
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: 3 mm Dilapan tent for 16-20 hours
Number of subjects: 450
Study: 31869461

Group type: EXPERIMENTAL
Intervention: Extensive intraoperative peritoneal lavage (EIPL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 0
Study: 30772404

Group type: EXPERIMENTAL
Intervention: Attachment and Biobehavioral Catch‐up (ABC) intervention
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 96
Study: 28401790

Group type: EXPERIMENTAL
Intervention: Iodixanol (iso-osmolar contrast media)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Iopromide (low-osmolar contrast media)
Number of subjects: 0
Study: 26159016

Group type: EXPERIMENTAL
Intervention: Qingfei Huoxue Recipe (QHR) combined with azithromycin
Number of subjects: 124

Group type: COMPARATOR
Intervention: Azithromycin (Control)
Number of subjects: 124
Study: 23806850

Group type: EXPERIMENTAL
Intervention: 25 mg subcutaneous progesterone daily for 11 days
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 50 mg subcutaneous progesterone daily for 11 days
Number of subjects: 25
Study: 21138376

Group type: EXPERIMENTAL
Intervention: Low-dose SBE (2,000 mg of SBE/day)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: High-dose SBE (4,000 mg of SBE/day)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Positive control (1,140 mg of pinitol/day)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Negative control (2,000 mg of lactose/day)
Number of subjects: 4
Study: 20556401

Group type: EXPERIMENTAL
Intervention: BioDynamix ColonRing™
Number of subjects: 23

Group type: COMPARATOR
Intervention: Standard double-stapled anastomosis
Number of subjects: 23
Study: 17212641

Group type: EXPERIMENTAL
Intervention: pegylated recombinant interferon‐alpha and ribavirin
Number of subjects: 231
Study: 15773565

Group type: EXPERIMENTAL
Intervention: Thoracic and scapular taping to change posture
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo control (not explicitly detailed)
Number of subjects: 120
Study: 11866010

Group type: EXPERIMENTAL
Intervention: 10 mg x kg(‐1) tobramycin once-daily
Number of subjects: 60

Group type: COMPARATOR
Intervention: 3.3 mg x kg(‐1) tobramycin thrice-daily
Number of subjects: 60
Study: 9674473

Group type: EXPERIMENTAL
Intervention: ANP group (n=20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (n=20)
Number of subjects: 40
Study: 7697949

Group type: EXPERIMENTAL
Intervention: Grapefruit juice
Number of subjects: 12

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 12
Study: 2653044

Group type: EXPERIMENTAL
Intervention: Timolol 0.5%-Pilocarpine 4% twice a day
Number of subjects: 80

Group type: COMPARATOR
Intervention: Timolol 0.5% twice a day plus Pilocarpine 4% three times a day
Number of subjects: 80
Study: 134724

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (2 puffs, 0.02 mg per puff)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Isoprenaline (2 puffs, 0.1 mg per puff)
Number of subjects: 12
Study: 31454444

Group type: COMPARATOR
Intervention: Motivational Enhancement Therapy (MET)
Number of subjects: 693

Group type: EXPERIMENTAL
Intervention: Motivational Enhancement Therapy + Community Reinforcement Approach for Seniors (MET + CRA-S)
Number of subjects: 693
Study: 30768121

Group type: EXPERIMENTAL
Intervention: BFP excision with hydrodissection (15 mL of a vasoconstricting anesthetic solution)
Number of subjects: 54

Group type: COMPARATOR
Intervention: BFP excision with 3 mL of lidocaine 2% with epinephrine
Number of subjects: 54
Study: 29154063

Group type: EXPERIMENTAL
Intervention: Silymarin (420mg divided into three equal 140-mg daily doses)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study: 24684534

Group type: EXPERIMENTAL
Intervention: Methylphenidate 10 mg daily
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 24
Study: 23090102

Group type: EXPERIMENTAL
Intervention: Desflurane (DES group; N=25)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sevoflurane (SEVO group; N=25)
Number of subjects: 50
Study: 22048580

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 20209981

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 28
Study: 17904909

Group type: EXPERIMENTAL
Intervention: 6-week psychosocial self-management intervention
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 61
Study: 14969841

Group type: EXPERIMENTAL
Intervention: Intramuscular matrine (100 mg daily for 90 days)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional liver‐protective drugs alone (control group)
Number of subjects: 120
Study: 11241028

Group type: EXPERIMENTAL
Intervention: Plasma Fourier-transform infrared (FT-IR) spectra classification
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Defined absorption regions of spectra
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of four absorption regions (nu=CH, nu(as)CH(3), nuC-O (amide I), nuC-O (carbonyle))
Number of subjects: 0
Study: 9205679

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Saline infusion without ibuprofen
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Saline loading after ibuprofen
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control (no ibuprofen)
Number of subjects: 5
Study: 7962396

Group type: EXPERIMENTAL
Intervention: Prostaglandin F2 alpha injection
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: High-risk group identified by serum progesterone values > 20 nmol/l and daily HCG changes > +50 IU/l/day
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Patients without high-risk indicators
Number of subjects: 60
Study: 3304782

Group type: EXPERIMENTAL
Intervention: Human protamine sodium insulin 0.6 mg%
Number of subjects: 7

Group type: COMPARATOR
Intervention: Human isophane zinc insulin
Number of subjects: 7
Study: 30462717

Group type: EXPERIMENTAL
Intervention: Mindful Self-Compassion (MSC) training intervention
Number of subjects: 13
Study: 27012405

Group type: EXPERIMENTAL
Intervention: Omecamtiv Mecarbil (OM)
Number of subjects: 606

Group type: EXPERIMENTAL
Intervention: Omecamtiv Mecarbil (OM) high-dose cohort
Number of subjects: 606

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 606
Study: 25656094

Group type: EXPERIMENTAL
Intervention: Trivalent influenza vaccine
Number of subjects: 31

Group type: COMPARATOR
Intervention: No vaccine
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Influenza vaccine (healthy individuals)
Number of subjects: 31

Group type: COMPARATOR
Intervention: No vaccine (healthy individuals)
Number of subjects: 31
Study: 23672380

Group type: EXPERIMENTAL
Intervention: Combination feedback (CB)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Self-feedback (SE)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control (CT)
Number of subjects: 43
Study: 21039597

Group type: EXPERIMENTAL
Intervention: SRD441 ointment
Number of subjects: 93

Group type: COMPARATOR
Intervention: Vehicle ointment
Number of subjects: 93
Study: 19186343

Group type: EXPERIMENTAL
Intervention: LI4 unilateral
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: LI4 bilateral
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: LI11 unilateral
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: LI4 and LI11 combined unilateral
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 22
Study: 16625109

Group type: EXPERIMENTAL
Intervention: Contrast medium containing 300 mg of iodine (Iomeron 300) at a flow rate of 3.3 mL/s
Number of subjects: 60

Group type: COMPARATOR
Intervention: Contrast medium containing 400 mg of iodine (Iomeron 400) at a flow rate of 2.5 mL/s
Number of subjects: 60
Study: 14628939

Group type: EXPERIMENTAL
Intervention: Sulfadoxine-pyrimethamine (SP) treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Presence of DHFR Arg-59 and DHPS Glu-540 mutations
Number of subjects: 0
Study: 11134122

Group type: EXPERIMENTAL
Intervention: 17-beta estradiol (E(2))
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Progesterone (P)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 17-beta estradiol (E(2)) with Progesterone (P)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 27
Study: 9424839

Group type: EXPERIMENTAL
Intervention: Rehabilitation complex including 'dry' effervescent baths, magnetolaser therapy applied to the heart area, cryomassage of the abdomen.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rehabilitation complex including 'dry' effervescent baths, magnetolaser therapy applied to the heart area, cryomassage of the abdomen, plus dry air baths.
Number of subjects: 0
Study: 8340879

Group type: EXPERIMENTAL
Intervention: Sight of blood with decorated adhesive bandage
Number of subjects: 70

Group type: COMPARATOR
Intervention: Sight of blood with plain adhesive bandage
Number of subjects: 70

Group type: COMPARATOR
Intervention: No sight of blood with decorated adhesive bandage
Number of subjects: 70

Group type: COMPARATOR
Intervention: No sight of blood with plain adhesive bandage
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Age as a covariate
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Poker Chip Tool
Number of subjects: 70
Study: 3552295

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (35 mg acetylsalicylate per day for 7 days)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 31883278

Group type: EXPERIMENTAL
Intervention: Exergame
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Treadmill
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control
Number of subjects: 65
Study: 30050947

Group type: EXPERIMENTAL
Intervention: Mineralized solvent‐dehydrated bone allograft (MCBA)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Freeze‐dried mineralized bone allograft (FDBA)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Anorganic bovine bone (ABB)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Equine‐derived bone (EB)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Synthetic micro‐macroporous biphasic calcium‐phosphate block (HA‐β‐TCP 30/70)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Bioapatite‐collagen (BC)
Number of subjects: 6
Study: 26269281

Group type: EXPERIMENTAL
Intervention: Chevrolet MyLink system (one voice command)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Volvo Sensus system (multiple commands)
Number of subjects: 80
Study: 24389518

Group type: EXPERIMENTAL
Intervention: 150 mg·kg(‐1) body mass tyrosine (TYR)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Isocaloric quantity of whey powder (PLA)
Number of subjects: 7
Study: 22454410

Group type: EXPERIMENTAL
Intervention: Lower Atrial Septum (LAS) pacing
Number of subjects: 57

Group type: COMPARATOR
Intervention: Right Atrial Appendage (RAA) pacing
Number of subjects: 57
Study: 20012918

Group type: EXPERIMENTAL
Intervention: 70 mg alendronate once weekly (n = 23)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control (n = 23)
Number of subjects: 46
Study: 18686766

Group type: COMPARATOR
Intervention: Group 1 (control) - no blood contamination
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Group 2 - blood contaminated, rinsed with water
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Group 3 - blood contaminated, air-dried
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Group 4 - blood contaminated, rinsed and air-dried
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Group 5 - blood contaminated, no post-contamination treatment
Number of subjects: 75
Study: 15851341

Group type: EXPERIMENTAL
Intervention: 7-ms ascending ramp waveform (RAMP)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: 12-ms ascending ramp waveform (RAMP)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Biphasic truncated exponential waveform (BTE)
Number of subjects: 63
Study: 12649655

Group type: EXPERIMENTAL
Intervention: Brace with minimal tension
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Brace with 2.5 kg force tension
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Brace with 5 kg force tension
Number of subjects: 15

Group type: COMPARATOR
Intervention: No brace
Number of subjects: 15
Study: 9704793

Group type: EXPERIMENTAL
Intervention: Vaginal delivery
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cesarean section
Number of subjects: 60
Study: 8549578

Group type: EXPERIMENTAL
Intervention: Intense daily isometric and isokinetic leg exercise
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 12
Study: 2725453

Group type: EXPERIMENTAL
Intervention: Zopiclone 3.75 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Zopiclone 7.5 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31991755

Group type: EXPERIMENTAL
Intervention: Relationship intervention
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Co-parenting intervention
Number of subjects: 180

Group type: COMPARATOR
Intervention: Information control
Number of subjects: 180
Study: 29855386

Group type: EXPERIMENTAL
Intervention: Early motion and directed exercise (EMADE) intervention consisting of a non-weight-bearing progressive home exercise programme, complemented with manual therapy and education.
Number of subjects: 144

Group type: COMPARATOR
Intervention: Usual care consisting of immobilisation in a non-weight-bearing below-knee cast for 6 weeks.
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Early motion and directed exercise (EMADE) intervention
Number of subjects: 144

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 144
Study: 28628064

Group type: EXPERIMENTAL
Intervention: HIIT
Number of subjects: 44

Group type: COMPARATOR
Intervention: MICT
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: HIIT and MICT
Number of subjects: 44
Study: 26691355

Group type: EXPERIMENTAL
Intervention: Preload (10 ml/kg crystalloid before induction)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Coload (10 ml/kg crystalloid at the time of spinal anesthesia)
Number of subjects: 60
Study: 23402713

Group type: EXPERIMENTAL
Intervention: 1% milk (44 kcal/100 ml)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Orange juice (44 kcal/100 ml)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Regular cola (44 kcal/100 ml)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Diet cola (0 kcal)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Water (0 kcal)
Number of subjects: 29
Study: 21138519

Group type: EXPERIMENTAL
Intervention: Crushed lanthanum 1000 mg 3 times daily
Number of subjects: 11

Group type: COMPARATOR
Intervention: Chewed lanthanum 1000 mg 3 times daily
Number of subjects: 11
Study: 19483246

Group type: EXPERIMENTAL
Intervention: Health information leaflets
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Hydrochlorthiazide information sheets
Number of subjects: 398
Study: 17302877

Group type: EXPERIMENTAL
Intervention: Oestradiol (2 x 0.1 mg/day patches) for days 5-16
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Combined Oestradiol + Progesterone (200 mg/day for days 13-16)
Number of subjects: 8

Group type: COMPARATOR
Intervention: GnRH antagonist
Number of subjects: 8
Study: 15533381

Group type: EXPERIMENTAL
Intervention: 10,000 IU hCG
Number of subjects: 0

Group type: COMPARATOR
Intervention: 20,000 IU hCG
Number of subjects: 0
Study: 11125410

Group type: EXPERIMENTAL
Intervention: Topical application of 0.05% mometasone furoate
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40